Defibrillator Devices and Equipment Market Report 2026

The defibrillator devices and equipment market size has grown steadily in recent years. It will grow from $11.97 billion in 2025 to $12.43 billion in 2026 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to increasing incidence of sudden cardiac arrest, expansion of emergency medical services, growing awareness of cardiac emergency response, improvements in battery and capacitor technologies, wider hospital adoption of implantable defibrillators.

The defibrillator devices and equipment market size is expected to see strong growth in the next few years. It will grow to $15.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing public access defibrillation programs, rising adoption of connected cardiac monitoring systems, growing demand for home-based cardiac care, expansion of telecardiology services, advancements in miniaturized defibrillation technologies. Major trends in the forecast period include increasing deployment of automated external defibrillators in public spaces, rising adoption of wearable cardioverter defibrillators, growing integration of remote monitoring features, expansion of compact and portable defibrillator designs, enhanced focus on rapid response technologies.

Increasing healthcare expenditure is expected to propel the growth of the defibrillator devices and equipment market going forward. Healthcare expenditure refers to the total spending on healthcare goods and services, including personal medical care, public health initiatives, medical research, and health insurance programs. The rise in healthcare spending is largely driven by the growing prevalence of chronic diseases, which require long-term, resource-intensive treatment and advanced medical technologies, thereby increasing overall healthcare costs. Higher healthcare expenditure supports the defibrillator devices and equipment market by enabling hospitals, ambulatory surgical centers, emergency medical services, and public institutions to invest in advanced and reliable defibrillation systems that improve cardiac emergency outcomes. For instance, in April 2025, according to the American Medical Association, a US-based professional medical organization, health spending in the United States increased by 7.5% in 2023 to reach approximately US$4.9 trillion, or US$14,570 per capita, representing a significant acceleration compared with the 4.6% growth recorded in 2022. Therefore, rising healthcare expenditure and strengthening healthcare infrastructure are driving the growth of the defibrillator devices and equipment market.

Leading companies in the defibrillator devices and equipment market are focusing on developing innovative products, such as advanced defibrillators, to enhance patient outcomes and improve device functionality. Advanced defibrillators are medical devices designed to deliver electric shocks to the heart in cases of life-threatening arrhythmias, such as ventricular fibrillation or sudden cardiac arrest. For example, in June 2024, Stryker Healthcare, a US-based medical technology company, introduced the LIFEPAK 35 monitor/defibrillator. This device is designed to improve emergency medical care with its intuitive, lightweight design and a large touchscreen for customizable clinical workflows. Equipped with connected capabilities for continuous patient data monitoring, the LIFEPAK 35 addresses challenges faced by healthcare providers, including staff shortages and mental health concerns. Developed based on over a decade of research and feedback from healthcare professionals, it underscores Stryker's dedication to providing reliable tools for first responders and healthcare workers, ensuring consistent, high-quality care from roadside emergencies to hospital settings.

In May 2025, Safe Life AB, a Sweden-based supplier of life-saving solutions such as automated external defibrillators (AEDs), acquired AEDMAX.PL for an undisclosed amount. Through this acquisition, Safe Life sought to strengthen its presence in Europe by entering the Polish market, supporting faster customer-base expansion and enhancing its service-oriented offerings across Central and Eastern Europe. AEDMAX.PL is a Poland-based company that provides automated external defibrillators, first-aid equipment, and CPR and first-aid training, serving an established portfolio of local brands along with a substantial corporate and institutional customer base.

Major companies operating in the defibrillator devices and equipment market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., ZOLL Medical Corporation, Cardiac Science Corporation, Physio-Control Inc., Nihon Kohden Corporation, Defibtech LLC, Schiller AG, Biotronik Inc., LivaNova plc, HeartSine Technologies LLC, Mindray Medical International Limited, Metrax Engineering Ltd., CU Medical Systems Inc., Fukuda Denshi Co. Ltd., Innomed Technologies Inc., Progetti Srl, Weinmann Emergency Medical Technology GmbH + Co. KG, Bexen Cardio, Lepu Medical Technology (Beijing) Co. Ltd., Shenzhen XFT Medical Limited, Zhejiang Medtec Medical Devices Co. Ltd.

North America was the largest region in the global defibrillator devices and equipment market in 2025. Western Europe was the second-largest region in the defibrillator devices and equipment market. The regions covered in the defibrillator devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the defibrillator devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

Tariffs are influencing the defibrillator devices and equipment market by increasing costs of imported electronic circuits, energy storage components, sensors, and medical-grade plastics used in implantable and external defibrillators. Hospitals, emergency medical services, and public access programs in North America and Europe are most affected due to reliance on imported devices and components, while Asia-Pacific faces cost pressures in export-oriented production. These tariffs are increasing procurement costs and delaying equipment upgrades. At the same time, they are supporting localized manufacturing, regional assembly, and supply chain diversification for life-saving cardiac devices.

The defibrillator devices and equipment market research report is one of a series of new reports that provides defibrillator devices and equipment market statistics, including defibrillator devices and equipment industry global market size, regional shares, competitors with a defibrillator devices and equipment market share, detailed defibrillator devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the defibrillator devices and equipment industry. This defibrillator devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Defibrillator devices and equipment are essential for addressing critical cardiac arrhythmias and irregular heart rhythms in emergency situations, delivering high-energy electrical shocks to restore normal heart function.

Within the defibrillator market, the primary device categories encompass implantable defibrillators and external defibrillators. Implantable defibrillators are small, battery-powered devices strategically placed within the body to detect and correct irregular heartbeats. This category includes various types such as transvenous implantable cardioverter-defibrillators (T-ICDs), subcutaneous implantable cardioverter-defibrillators (S-ICDs), and cardiac resynchronization therapy-defibrillators (CRT-Ds), available as single or dual chamber devices. Meanwhile, external defibrillators consist of manual external defibrillators (MEDs), automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). These devices cater to multiple end-users, including hospitals, pre-hospital emergency services, the public access market, alternate care facilities, and home healthcare setups.

The defibrillator devices and equipment market consist of sales of instruments such as manual external defibrillator, implantable cardioverter defibrillator, manual internal defibrillator, automated external defibrillator, and wearable defibrillators. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.